Literature DB >> 1354319

Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.

R Enting, J de Gans, P Reiss, C Jansen, P Portegies.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354319     DOI: 10.1016/0140-6736(92)91764-y

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Diagnosis and treatment of viral encephalitis.

Authors:  A Chaudhuri; P G E Kennedy
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

Review 2.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDS.

Authors:  C Mussini; N Mongiardo; G Manicardi; F Trenti; A Alessandrì; F Paolillo; A Catania; M Portolani; M Pecorari; V Borghi; G Ficarra; A Cossarizza; B De Rienzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

4.  Cytomegalovirus encephalitis in an immunocompetent pregnant woman.

Authors:  W R Saliba; R Raz; Y Keness; L H Goldstein; A Reshef; M Elias
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-25       Impact factor: 3.267

Review 5.  Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

Review 6.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

7.  Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.

Authors:  M D de Jong; C A Boucher; D A Cooper; G J Galasso; B Gazzard; J M Lange; J S Montaner; D D Richman; H C Thomas
Journal:  Antiviral Res       Date:  1997-07       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.